What is the global market size of 3D Cell Culture Market?

Global 3D Cell Culture Market size was valued at USD 1.12 billion in 2021 and is poised to grow from USD 1.3 billion in 2022 to USD 4.77 billion by 2030, growing at a CAGR of 15.6% in the forecast period (2023-2030).

What is the key driver of Global 3D Cell Culture Market?

The increasing prevalence of chronic diseases, such as diabetes and kidney failure, has led to a rise in demand for organ transplantation. However, there is a shortage of organs available for transplantation. 3D cell culture technology can be used to develop functional organs for transplantation, which is driving the growth of the market. For example, Organovo, a biotechnology company, has developed 3D printed liver tissues for use in drug testing and transplantation research.

What is the key market trend for Global 3D Cell Culture Market?

Growing focus on personalized medicine: There is an increasing focus on personalized medicine, which requires the development of patient-specific models for drug testing and disease modeling. 3D cell culture technology can be used to create patient-specific models that can be used for personalized drug discovery and treatment. For instance, Hubrecht Organoid Technology (HUB) has developed a platform that uses patient-derived organoids for drug testing and personalized medicine.

Which region accounted for the largest share in Global 3D Cell Culture Market?

North America held the largest market share of 45.58% in 2022. This was due to factors such as advanced healthcare infrastructure, developed economies, the presence of key players, and strategic initiatives undertaken by them. Additionally, a supportive regulatory framework, government support for the development of three-dimensional culture models, and numerous research organizations and universities investigating different stem-cell based approaches are expected to further boost the regional market. For instance, the Harvard Stem Cell Institute is utilizing stem cells to revolutionize medicine for better outcomes.

3D Cell Culture Market Size, Share, Growth Analysis, By Product(Scaffold-based, Scaffold-free, Bioreactors, and Others), By Application(Cancer Research, Stem Cell Research & Tissue Engineering, and Others), By End User(Biotechnology and Pharmaceutical Companies, Academic & Research Institutes, and Others), By Region - Industry Forecast 2024-2031

Q: Who are the key vendors in the Global 3D Cell Culture Market?

' Thermo Fisher Scientific Inc. (US) ', ' Corning Incorporated (US) ', ' Merck KGaA (Germany) ', ' Lonza Group AG (Switzerland) ', ' Becton, Dickinson and Company (US) ', ' 3D Biotek LLC (US) ', ' InSphero AG (Switzerland) ', ' Synthecon Inc. (US) ', ' Tecan Trading AG (Switzerland) ', ' PromoCell GmbH (Germany) ', ' Greiner Bio-One International GmbH (Austria) ', ' Avantor, Inc. (US) ', ' Sartorius AG (Germany) ', ' Nano3D Biosciences, Inc. (US) ', ' MIMETAS B.V. (Netherlands) ', ' QGel SA (Switzerland) ', ' TissUse GmbH (Germany) ', ' SynVivo, Inc. (US) ', ' Emulate, Inc. (US) ', ' CN Bio Innovations Ltd. (UK) '.

Report ID: SQMIG35H2246 | Region: Global | Published Date: July, 2024
Pages: 157 | Tables: 90 | Figures: 76

3D Cell Culture Market Dynamics

3D Cell Culture Market Drivers

Demand for Personalized Medicine

3D cell culture plays a vital role in the development of personalized medicine as it is the only way available to mimic human tissues in the most accurate way possible. Therefore, high demand for personalized medicine will also fuel market growth through 2031.

High Investments in Cell Research

Advancements in molecular biology have led to increased investments in the research of cells and cell therapy segments. From private to public, almost all organizations are investing and supporting cell research in some or the other way.

Restraints

Limited Standardization

The use of 3D cell culture is still in its initial stages, and this is why the technology has not been standardized around the world. This lapse in standardization results in variability of results and thereby slows down 3D cell culture market growth as well.

Limited Scalability

Scaling 3D cell cultures is a major issue as maintaining uniform cell growth and function is still a concept that’s very unclear to researchers. This is why large-scale adoption of 3D cell culture is not possible now and thereby impedes 3D cell culture demand.

3D Cell Culture Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

3D Cell Culture Market size was valued at USD 1.3 Billion in 2022 and is poised to grow from USD 1.31 Billion in 2023 to USD 11.79 Billion by 2031, growing at a CAGR of 18.2% during the forecast period (2024-2031).

3D cell culture market players should focus on collaborations and partnerships to share their expertise and fast-track the development of novel 3D cell culture products. Developing affordable reagents and equipment required for 3D cell cultures will also offer good business scope for new entrants in the market. Investing in research will be a non-negotiable strategy for all 3D cell culture companies operating around the world. 'Thermo Fisher Scientific Inc. (US) ', 'Corning Incorporated (US) ', 'Merck KGaA (Germany) ', 'Lonza Group AG (Switzerland) ', 'Becton, Dickinson and Company (US) ', '3D Biotek LLC (US) ', 'InSphero AG (Switzerland) ', 'Synthecon Inc. (US) ', 'Tecan Trading AG (Switzerland) ', 'PromoCell GmbH (Germany) ', 'Greiner Bio-One International GmbH (Austria) ', 'Avantor, Inc. (US) ', 'Sartorius AG (Germany) ', 'Nano3D Biosciences, Inc. (US) ', 'MIMETAS B.V. (Netherlands) ', 'QGel SA (Switzerland) ', 'TissUse GmbH (Germany) ', 'SynVivo, Inc. (US) ', 'Emulate, Inc. (US) ', 'CN Bio Innovations Ltd. (UK)'

3D cell culture plays a vital role in the development of personalized medicine as it is the only way available to mimic human tissues in the most accurate way possible. Therefore, high demand for personalized medicine will also fuel market growth through 2031.

Integration with Microfluidics: Microfluidic (organ-on-a-chip) technology has come a long way and integrating 3D cell culture with this could be the first of mankind to make artificial organs from actual human tissue. Moreover, this could also help researchers emulate and stimulate more complex conditions in organs for research purposes.

Robust spending on medical research in the North American region makes it a leader in the global 3D cell culture market. The presence of multiple pharmaceutical and biotechnology companies focusing on cell research and supportive government initiatives are helping this region maintain its dominance. Rising availability of funds to advanced 3D cell culture research and growing demand for regenerative medicine are also making the United States a top market in this region. The developed healthcare infrastructure of countries in this region also contributes to the high market share.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

3D Cell Culture Market Dynamics

3D Cell Culture Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of 3D Cell Culture Market?

Who are the key vendors in the 3D Cell Culture Market?

What is the key driver of 3D Cell Culture Market?

What is the key market trend for 3D Cell Culture Market?

Which region accounted for the largest share in 3D Cell Culture Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300